Srikanth Boinapally

Srikanth Boinapally

Johns Hopkins University

H-index: 14

North America-United States

About Srikanth Boinapally

Srikanth Boinapally, With an exceptional h-index of 14 and a recent h-index of 12 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Cancer Therapeutics and Synthetic Organic Chemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

Prostate-specific membrane antigen (psma)-targeted prodrug for selective killing of cells expressing psma

Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics

Feasibility of spectra-based quantification algorithm for non-linear photoacoustic contrast agents

Low molecular weight and polyamidoamine (pamam) dendrimer based psma-specific dual contrast agents for optical and photoacoustic imaging and theranostic agents for treating …

Correction to: Hetero-bivalent agents targeting FAP and PSMA

Preclinical evaluation of 213Bi-and 225Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer

A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile

Dual contrast agents for fluorescence and photoacoustic imaging: evaluation in a murine model of prostate cancer

Srikanth Boinapally Information

University

Position

Johns Hopkins School of Medicine

Citations(all)

437

Citations(since 2020)

274

Cited By

223

hIndex(all)

14

hIndex(since 2020)

12

i10Index(all)

17

i10Index(since 2020)

13

Email

University Profile Page

Johns Hopkins University

Google Scholar

View Google Scholar Profile

Srikanth Boinapally Skills & Research Interests

Cancer Therapeutics and Synthetic Organic Chemistry

Top articles of Srikanth Boinapally

Title

Journal

Author(s)

Publication Date

Prostate-specific membrane antigen (psma)-targeted prodrug for selective killing of cells expressing psma

Nanotheranostics

Ethel J Ngen

Ying Chen

Babak Behnam Azad

Srikanth Boinapally

Desmond Jacob

...

2021

Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics

Molecules

Srikanth Boinapally

Suresh Alati

Zirui Jiang

Yu Yan

Alla Lisok

...

2023/8/21

Feasibility of spectra-based quantification algorithm for non-linear photoacoustic contrast agents

Liudmila Serebrennikova

Shang Gao

Ryo Murakami

Srikanth Boinapally

Martin G Pomper

...

2023/3/9

Low molecular weight and polyamidoamine (pamam) dendrimer based psma-specific dual contrast agents for optical and photoacoustic imaging and theranostic agents for treating …

2022/12/22

Correction to: Hetero-bivalent agents targeting FAP and PSMA

European Journal of Nuclear Medicine and Molecular Imaging

Srikanth Boinapally

Alla Lisok

Gabriela Lofland

Il Minn

Yu Yan

...

2022/11/1

Preclinical evaluation of 213Bi-and 225Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer

Journal of Nuclear Medicine

Sangeeta Ray Banerjee

Ala Lisok

Il Minn

Anders Josefsson

Vivek Kumar

...

2021/7/1

A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile

Scientific reports

Srikanth Boinapally

Hye-Hyun Ahn

Bei Cheng

Mary Brummet

Hwanhee Nam

...

2021/3/29

Dual contrast agents for fluorescence and photoacoustic imaging: evaluation in a murine model of prostate cancer

Nanoscale

Wojciech G Lesniak

Yixuan Wu

Jeeun Kang

Srikanth Boinapally

Sangeeta Ray Banerjee

...

2021

PSMA-TARGETED PAMAM DENDRIMERS FOR SPECIFIC DELIVERY OF IMAGING, CONTRAST AND THERAPEUTIC AGENTS

2020/6/18

See List of Professors in Srikanth Boinapally University(Johns Hopkins University)